New Zealand
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 162.76 M
|
Dec. 31, 2023 | USD 7.11 | 0.74% |
|
New Zealand |
|
2 |
USD 118.06 M
|
March 31, 2024 | USD 2.51 | 0.12% |
|
New Zealand |
|
3 |
USD -1.31 M
|
March 31, 2024 | USD 1.57 | 0.35% |
|
New Zealand |
|
4 |
USD -6.36 M
|
March 31, 2024 | USD 1.65 | -0.66% |
|
New Zealand |
|
5 |
USD -76.93 M
|
March 31, 2024 | USD 21.45 | 2.32% |
|
New Zealand |
The Health Care company in New Zealand with the highest Net Cash Used Provided By Financing Activities is Summerset Group Holdings Limited (NZSE: SUM.NZ) at USD 162.76 M.
The Health Care company in New Zealand with the lowest Net Cash Used Provided By Financing Activities is Fisher & Paykel Healthcare Corporation Limited (NZSE: FPH.NZ) at USD -76.93 M.
The top 10 Health Care companies in New Zealand by Net Cash Used Provided By Financing Activities are Summerset Group Holdings Limited, Ryman Healthcare Limited, Third Age Health Services Limited, AFT Pharmaceuticals Limited and Fisher & Paykel Healthcare Corporation Limited.
The bottom 10 Health Care companies in New Zealand by Net Cash Used Provided By Financing Activities are Fisher & Paykel Healthcare Corporation Limited, AFT Pharmaceuticals Limited, Third Age Health Services Limited, Ryman Healthcare Limited and Summerset Group Holdings Limited.